Robert J. Applegate, MD

Frederic R. Kahl , MD;

William C. Little , MD;

Superior In-Hospital and 30-Day Outcomes with Abciximab Versus Eptifibatide: A Contemporary Analysis of 495 Consecutive Percutan

Women have been shown historically to have a greater risk of complications than men following invasive procedures.1–5 The increased incidence of complications in women appears to occur independently of other factors known to influence the...

Women have been shown...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Propensity Score Analysis of Vascular Complications after
Diagnostic Cardiac Catheterization and Percutaneous Coronary Interven

Bharathi Upadhya , MD;

David C. Sane , MD;

Efthymios N. Deliargyris , MD;

Over the past decade clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition dramatically reduces the ischemic complications of percutaneous coronary intervention (PCI).1–6 Currently, there are 3...

Over the past decade clinical...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;

Differences in Baseline Characteristics and In-hospital Outcomes in Patients with or without Prior Stroke Undergoing Percutaneou

Renato M. Santos , MD;

Cardiac catheterization and PCI are usually performed by percutaneous access using the femoral artery. Following completion of the procedure, hemostasis is traditionally performed by manual compression, followed by 6 hours of bed rest....

Cardiac catheterization and PCI...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Bharathi Upadhya , MD;

David C. Sane , MD;

Efthymios N. Deliargyris , MD;

Automated Contrast Injection in Contemporary Practice during Cardiac Catheterization and PCI: Effects on Contrast-Induced Nephr

Percutaneous coronary intervention (PCI) is increasingly used in patients with high-risk baseline characteristics.1–4 A prior stroke may identify patients who are at higher risk for post-PCI complications. However, no comparative data exist...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Jason Call , MD;

Renato M. Santos , MD;

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;

PCI with and without Abciximab after Upstream Eptifibatide Use: Outcomes in High-Risk Patients

Contrast-induced nephropathy (CIN) is a common problem after cardiac catheterization and percutaneous coronary intervention (PCI), and is associated with substantial morbidity and mortality.1–3 The etiology of CIN has not been clearly...

Contrast-induced nephropathy...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Talal T. Baki , MD;

William C. Little , MD;

Culprit Vessel PCI versus Traditional Cath and PCI for STEMI

David C. Sane , MD;

Mark A. Grabarczyk , MD;

Jason E. Goodin , BA;

Sidney Statonk , MD;

Several clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition reduces the ischemic complications of percutaneous coronary interventions (PCI).1–4 Comparative data between agents, however, are very...

Several clinical trials have...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Stacy H. Graham , MD;

William C. Little , MD;

Renato M. Santos , MD;

Conversations in Cardiology: Should You Still Prepare the Femoral Site for Radial Cases?

Achieving rapid reperfusion in patients with ST-elevation myocardial infarction (STEM) has been established as an effective and life-saving treatment for these patients. The mortality benefit of primary percutaneous coronary intervention...

Achieving rapid reperfusion in...

08/01/2008

Journal of Invasive Cardiology

04/30/2015

Morton J. Kern , MD, MSCAI, FACC, FAHA;

David J. Cohen , MD, MPH, MSc;

Target Lesion Revascularization after Bare-Metal or Drug-Eluting Stents: Clinical Presentations and Outcomes

Ajay J. Kirtane , MD, SM;

Peter Ver Lee , MD;

David E. Kandzari , MD;

Christopher J. White , DO, MD;

Mauricio G. Cohen , MD, FACC;

Samuel M. Butman , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

Aaron V. Kaplan ;

Prashant Kaul , MD, FACC, FSCAI;

Malcolm R. Bell , MD;

Mladen I. Vidovich , MD;

Kirk N. Garratt , MD, MSc;

John Hodgson , MD, FSCAI, FACC;

Michael Krucoff ;

Ramon Quesda ;

Fred Resnick ;

Gus Pichard, Washington Heart Center, asks, “Mort, who among the radialists has stopped shaving the groin?

Gus Pichard, Washington Heart...

04/30/2015

Cath Lab Digest

Original Contribution

06/02/2010

Renato M. Santos , MD;

Kevin R. Hayes , MD;